[ad_1]
CANTON, Conn., May 8, 2022 /PRNewswire/ — Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 312021.
“Revenue and profitability in Q1 were essentially flat as compared to the previous year,” said Ross BjellaKelyniam’s Chairman and CEO. “2021 Q1 revenue was artificially high due to pent up Covid related demand for custom implants in March. 2022 Q1 revenue came in as forecast for the quarter. The company also shipped the first implants through our partnership with Finceramica and I expect profit and sales growth following the CustomizedBone launch.”
Financial highlights for the three months ended
Full story available on Benzinga.com [ad_2]
Source link
